MarketWatch

Otsuka Announces FDA Acceptance and Priority Review of New Drug Application for Centanafadine for the Treatment of ADHD in Children, Adolescents, and Adults

The MarketWatch News Department was not involved in the creation of this content. -- Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents, and adults. It is ...
BioSpace

Otsuka Announces FDA Acceptance and Priority Review of New Drug Application for Centanafadine for the Treatment of ADHD in Children, Adolescents, and Adults

Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents, and adults. It is a novel norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI). The ...
Times Argus

Otsuka Announces FDA Acceptance and Priority Review of New Drug Application for Centanafadine for the Treatment of ADHD in Children, Adolescents, and Adults

Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announce that the U.S. Food and Drug Administration (FDA) has accepted for priority ...
IEEE

Optimizing Hardware Resources: A Study on Power, and Temperature in Priority Encoder

Abstract: This study presents a novel method for building an energy-efficient priority encoder-more especially, for FPGA families-that is based on Energy optimization is sometimes disregarded in ...
IEEE

Photoelectric Vulnerability Analysis and Experimental Validation of Incremental Optical Encoders in Internet of Things Applications

Abstract: Incremental optical encoders are widely used as photoelectric sensing components in direct current motor servo systems, but their inherent susceptibility to optical interference ultimately ...